ATNF 180lifesciences.com: יחס חוב להיוון בספרים

ETHZilla Corporation (ATNF) bases its autonomy on smart contracts and decentralized protocols. The debt-to-book capitalization financing structure visualizes this transition, with the metric value standing at 1.16. The business previously relied on anti-inflammatory drug patents; however, the closure of biotech programs and a lack of stable revenue led to a dependence on remaining balance sheet liquidity.

ETHZilla Corporation (ATNF) develops innovative biotechnologies and digital methods to combat chronic inflammation. The capital intensity of such research makes the financing structure critical for business sustainability. This ratio compares the total volume of borrowed funds to the book value of equity. The metric determines the degree of financial autonomy and the issuer's potential bankruptcy risk. By analyzing this financial leverage trend chart, an investor assesses the balance between debt load and resource efficiency.